Entering text into the input field will update the search result below

Haemonetics down 7% on agreement loss from CSL Pharma

Apr. 20, 2021 11:08 AM ETCSL Limited (CSLLY) Stock, HAE StockHAE, CSLLYBy: Jonathan Block, SA News Editor2 Comments
  • CSL Pharma, a division of CSL Limited (OTCPK:CSLLY), will not renew a supply agreement with Haemonetics (NYSE:HAE) for the use PCS2 Plasma Collection System devices and the purchase of plasmapheresis kits.
  • The agreement expires in June 2022 and accounted for $117M -- 11.8% -- of overall

Recommended For You

Related Stocks

SymbolLast Price% Chg
HAE
--
CSLLY
--